Welcure Drugs & Pharmaceuticals Ltd

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Welcure Drugs & Pharmaceuticals Ltd has not filed a concall transcript in the last 4 quarters.

Filings

10 shown · 10 published by the exchange

14 Jul 2026
Board meeting
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.
19 Jun 2026
Filing
Resignation of Company Secretary / Compliance Officer
19 Jun 2026
Board meeting
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026
01 Jun 2026
Filing
Newspaper Publication
30 May 2026
Filing
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May 2026
Results
Audited Standalone Financial Result For The Quarter And Year Ended 31St March, 2026
29 May 2026
Board meeting
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of The Welcure Drugs And Pharmaceuticals Limited Held Today I.E. Friday, 29Th May, 2026
22 May 2026
Board meeting
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter/Year Ended 31St March, 2026 Along With Statement Of Assets And Liabilities And Cash Flow Statement For The Year Ended 31St March, 2026.
23 Apr 2026
Filing
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
03 Apr 2026
Filing
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 14 Jul 2026.